Snowball today | 雪球

This year has been bloody and bloody in the market. Many stocks have been discounted, and public and private equity has also retreated hugely. I believe that every investor with a position at this time will be in a bad mood. As the saying goes, investing is the realization of knowledge. But cognition is only […]

New China Insurance’s performance in the first three quarters fell by 7%, profit fell by 56%, revenue in the third quarter fell by 10.5%, profit fell by 99.8%, and the profit attributable to the parent was 3 million yuan. I think it is easy for everyone to think about it. It manages trillions of assets

As of the close on the 28th, Kweichow Moutai fell by 27.37% in October, and it fell too hard. I don’t know which fund managers increased their positions more in the third quarter, and which fund managers reduced their positions more. For fund managers, I can’t say whether this action of adding and reducing positions

As of last night, all companies with relatively heavy A-share positions have released their third quarterly reports. Currently, according to the market value of A-shares, the relatively heavy positions are National Defense ETF, Aerospace Hongtu, Fudan Microelectronics, Ziguang Guowei, and AVIC Optoelectronics. , Mindray Medical, except for Mindray Medical, the rest are military stocks, or

1. Maotai Although the 5-year line of Kweichow Moutai was directly smashed by heavy volume, the stock price had dropped to 1360 yuan on October 28, but the net purchase of Shanghai Stock Connect that day was 78.07 million, which was on October 10. For the first time after falling from above 1800 yuan, the

$BYD(SZ002594)$ BYD Electronics and BYD Co., Ltd. have just announced their third-quarter results. In the third quarter of this year alone, BYD Co., Ltd. made a profit of 5.716 billion, basically in the midpoint of the forecast range (5.5-5.9 billion). The most eye-catching figure in this three-quarter report is the profitability of BYD’s auto business,

It’s not easy to create, please pay attention and like 🙂 Regarding the topic of investment cost and value of equity investment held by Tencent, I wrote an article some time ago: How does Tencent return on investment & external investment, recovery data summary , this article counts Tencent’s current external equity investment (listed +

Rongsheng Petrochemical, which was the first to announce its third quarterly report and caused a market uproar, was the only one that made a profit in Q3 in the large refining and chemical industry, showing the resilience of Zhejiang Petrochemical. Before the large-scale refining and chemical production of Dongfang Shenghong, the profit contribution of photovoltaic

As of the end of June, there were 139 fund management companies in my country, managing more than 10,000 public funds. As of the end of June, the net value of public funds was 26.79 trillion yuan, and the market value was 5.95 trillion yuan. Covering more than 90% of the stocks in the two

After reading the financial report, just chat a few words. Speaking of which, the issues facing Intel (INTC) are less complicated. Looking at the processor business alone, there are mainly three pieces: desktops, notebooks, and servers (workstations can be counted in it). At present, the Intel 7 process used by the 13th generation Core Duo,

It’s time to overturn our inherent cognition. Everyone can feel the difficulty of investing in 2022, but the “poor baby” I didn’t expect is not Manager Cai and Goddess Ge, nor is it Baijiu and Zhonggai. Let me first give you a set of data (as of October 27, the yield of each benchmark fund

In the previous articles, we introduced the allocation-based perspective and the transaction-based perspective to analyze the appropriate management size of the fund. Today, I will discuss how to simplify the complexity and simplify the indicators to analyze the appropriate management scale of public funds. First, the ratio of the calculated combined value of fund size

Recently, the pharmaceutical sector has felt that their respective ups and downs have been mixed. Today, one is the traditional Chinese medicine sector, and the other is the OK lens. Finally, there is a province saying that it will be centrally purchased. As a result, from the OK lens manufacturer to the eye hospital, there